Zepp Health Corporation shares rise 1.65% in after-hours after projecting 30% revenue growth for Q2 2025 and positive reviews for new products.

Zepp Health Corporation surged 1.65% in after-hours trading, driven by the company's forecast of a 30% revenue growth for the second quarter of 2025, its first increase in three years, and a 10% year-over-year revenue growth for its own brand Amazfit in the first quarter of 2025, with a gross margin of 37.3%. Additionally, the company's new products, Amazfit Active 2 and Bip 6, have received positive reviews and boosted sales.